Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study

[1]  A. Paterson,et al.  Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[2]  B. Zinman,et al.  Renal outcomes in patients with type 1 diabetes and macroalbuminuria. , 2014, Journal of the American Society of Nephrology : JASN.

[3]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[4]  Merlin C. Thomas,et al.  The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.

[5]  T. Uzu,et al.  Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 Diabetes , 2007, Diabetes.

[6]  K. Isshiki,et al.  Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. , 2005, Diabetes.

[7]  Merlin C. Thomas,et al.  Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.

[8]  M. Nieminen,et al.  Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study , 2005, Hypertension.

[9]  O. Pedersen,et al.  Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  B. Brenner,et al.  Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.

[11]  N. Chaturvedi,et al.  Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study , 2004, Diabetologia.

[12]  L. Sechi,et al.  Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.

[13]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[14]  H. Parving,et al.  Remission of nephrotic-range albuminuria in type 1 diabetic patients. , 2001, Diabetes care.

[15]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[16]  H. Parving,et al.  Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. , 2001, Kidney international.

[17]  G. Viberti,et al.  Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. , 2000, Diabetes care.

[18]  J. Chan,et al.  Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. , 2000, Kidney international.

[19]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[20]  J. Tuomilehto,et al.  Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland , 1998, Diabetologia.

[21]  K Borch-Johnsen,et al.  Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study , 1996, BMJ.

[22]  J. Wikstrand,et al.  Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. , 1996, American journal of hypertension.

[23]  K. Forrest,et al.  The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  K. Borch-Johnsen,et al.  Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes , 1996, BMJ.

[25]  S. Greenhouse,et al.  Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group. , 1994, Kidney international.

[26]  S. Kreiner,et al.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. , 1987, British medical journal.

[27]  C. Mogensen,et al.  Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.

[28]  H. Parving,et al.  Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. , 1982, Acta endocrinologica.

[29]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.

[30]  J. Kirkpatrick.  Albuminuria and Risk of Cardiovascular Events , Death , and Heart Failure in Diabetic and Nondiabetic Individuals , 2002 .